SECOND EXTENSION - GRANTED
granted
on 27 Jun 2024
Last Applicant/ Owned by
3545 Cray Court
San Diego
CA
92121
Serial Number
97301650 filed on 08th Mar 2022
Registration Number
N/A
Correspondent Address
Marilyn F. Kelly
Marilyn F. Kelly Bristol-Myers Squibb Company
Trademark Dept., Mailstop D.4243
Princeton, NJ 08648-4000
United States
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
MTYEKA
research and development of pharmaceuticals in the field of oncology; providing information in the field of scientific and medical research related to oncology; research and development of pharmaceuticals; providing information in the field of scientific and medical research related to pharmaceuticals pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for use in Read More
Classification Information
Class [042]
Computer & Software Services & Scientific Services
research and development of pharmaceuticals in the field of oncology; providing information in the field of scientific and medical research related to oncology; research and development of pharmaceuticals; providing information in the field of scientific and medical research related to pharmaceuticals
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [005]
Pharmaceutical Products
pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for use in oncology; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for the treatment of bladder cancer; pharmaceutical preparations for the treatment of lung cancer; pharmaceutical preparations for the treatment of renal cancer; pharmaceutical preparations for the treatment of renal cell carcinoma; pharmaceutical preparations for the treatment of squamous cell carcinoma; pharmaceutical preparations for the treatment of head and neck squamous cell carcinoma; pharmaceutical preparations for the treatment of oral cavity squamous cell carcinoma; pharmaceutical preparations for the treatment of colorectal cancer; pharmaceuticals comprising small molecules for the treatment of cancer; pharmaceuticals comprising small molecules for the treatment of bladder cancer; pharmaceuticals comprising small molecules for the treatment of lung cancer; pharmaceuticals comprising small molecules for the treatment of renal cancer; pharmaceuticals comprising small molecules for the treatment of renal cell carcinoma; pharmaceuticals comprising small molecules for the treatment of squamous cell carcinoma; pharmaceuticals comprising small molecules for the treatment of head and neck squamous cell carcinoma; pharmaceuticals comprising small molecules for the treatment of oral cavity squamous cell carcinoma; pharmaceuticals comprising small molecules for the treatment of colorectal cancer; pharmaceutical products for the treatment of cancer; pharmaceutical products for use in oncology; pharmaceutical products for the treatment of infectious diseases; pharmaceutical products for the treatment of bladder cancer; pharmaceutical products for the treatment of lung cancer; pharmaceutical products for the treatment of renal cancer; pharmaceutical products for the treatment of renal cell carcinoma; pharmaceutical products for the treatment of squamous cell carcinoma; pharmaceutical products for the treatment of head and neck squamous cell carcinoma; pharmaceutical products for the treatment of oral cavity squamous cell carcinoma; pharmaceutical products for the treatment of colorectal cancer; pharmaceuticals comprising compounds for the treatment of cancer; pharmaceuticals comprising inhibitors for the treatment of cancer; pharmaceuticals for the treatment of solid tumors
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 97301650
Mark Type
No Service Mark
Attorney Docket Number
No 00163829-US
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 25th Nov 2024 | SOU TEAS EXTENSION RECEIVED |
| 27th Jun 2024 | SOU EXTENSION 2 FILED |
| 27th Jun 2024 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| 27th Jun 2024 | SOU EXTENSION 2 GRANTED |
| 27th Jun 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 27th Jun 2024 | SOU TEAS EXTENSION RECEIVED |
| 27th Jun 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 27th Jun 2024 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| 16th Dec 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 14th Dec 2023 | SOU EXTENSION 1 GRANTED |